
GTP Bioways, a CDMO specialising in the production of biotherapies and nanotherapies, has invested €12m (US$14m) into two new biopharmaceutical production lines at its site in Toulouse. The first line will be dedicated to production using microbial systems (bacteria and yeast). With a capacity of 300l, it will be operational in the first quarter of…